Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 21, 2015

View Archived Issues

JAK2 inhibitor shows promise for the treatment of leukemia

Factor XIa and KLKB1 inhibitors reported in BMS patent

Apricus seeks partnering for Femprox in female sexual dysfunction

BioSyent acquires Canadian rights to Photocure's Cysview

Biota advances RSV program with start of phase I trial of BTA-585

LY-3130481: a TARPgamma8-dependent AMPA antagonist for epilepsy

Odomzo approved in E.U. for locally advanced basal cell carcinoma

CSIR scientists describe PDE5A inhibitors

AM-Pharma discloses phosphatase-like proteins

Bristol-Myers Squibb synthesizes AAK1 inhibitors

Pan-Pim kinase inhibitors investgated at Amgen for anticancer activity

Janus Biotherapeutics collaborates with Roche on autoimmune diseases

ExeGi Pharma announces clinical trial of probiotic Visbiome in HIV infection

Sprout Pharmaceuticals to be acquired by Valeant

Cellceutix reports results from phase I trial of Kevetrin in solid tumors

MAP/MAPKAP-2 inhibitor MK-2684 shows promise for the treatment of asthma

Isotope Technologies acquires DOTA-zoledronate for radiotherapy and imaging

EMA to review MAA for palbociclib plus endocrine therapy for HR+/HER2- metastatic breast cancer

4D Pharma's IBS candidate Blautix enters phase I trial

MAA validated for emtricitabine/rilpivirine/tenofovir combination tablet

Janssen starts phase II trial of sirukumab in patients with depression

Novartis acquires rights to ofatumumab for autoimmune disease from GSK

Janssen applies for E.U. approval of long-acting paliperidone palmitate

EMA accepts Takeda's MAA for ixazomib

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...